Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
CJC-1295 / Ipamorelin is a dual-peptide formulation commonly used in growth hormone pathway research. By combining a growth hormone releasing hormone analog with a selective ghrelin receptor agonist, this pairing works through complementary signaling mechanisms involved in natural growth hormone release.
This peptide combination is frequently used in research settings focused on recovery processes, sleep quality pathways, and body composition signaling. The coordinated interaction between CJC-1295 and Ipamorelin allows for investigation into balanced growth hormone pulse activity and downstream metabolic pathways.
Supports natural growth hormone signaling linked to recovery and physical performance
Helps the body recover faster after intense training or physical stress
Promotes deeper sleep and supports overnight repair processes
Supports lean muscle maintenance while helping regulate fat metabolism
Helps maintain balanced and consistent growth hormone release patterns
CJC-1295 functions as a growth hormone releasing hormone analog that interacts with receptors responsible for stimulating growth hormone signaling pathways. Ipamorelin acts as a selective ghrelin receptor agonist that promotes growth hormone pulse activity through a separate but complementary mechanism.
When combined, these peptides influence two different regulatory pathways associated with endogenous growth hormone release. This dual-pathway activity allows researchers to examine coordinated signaling related to recovery processes, metabolic function, and regenerative biological pathways.
Compound: CJC-1295 / Ipamorelin Peptide Blend
Form: Lyophilized Powder
Chemical Name: CJC-1295 (Modified Growth Hormone Releasing Hormone Analog)
Ipamorelin (Pentapeptide Growth Hormone Secretagogue)
Molecular Weight: CJC-1295: ~3647.2 g/mol Ipamorelin: ~711.9 g/mol
Appearance: White to off-white sterile lyophilized powder
Research Application: Growth hormone secretagogue research, metabolic pathway studies, recovery signaling analysis, and peptide interaction research.
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.
CJC-1295 / Ipamorelin is a dual-peptide formulation commonly used in growth hormone pathway research. By combining a growth hormone releasing hormone analog with a selective ghrelin receptor agonist, this pairing works through complementary signaling mechanisms involved in natural growth hormone release.
This peptide combination is frequently used in research settings focused on recovery processes, sleep quality pathways, and body composition signaling. The coordinated interaction between CJC-1295 and Ipamorelin allows for investigation into balanced growth hormone pulse activity and downstream metabolic pathways.
Supports natural growth hormone signaling linked to recovery and physical performance
Helps the body recover faster after intense training or physical stress
Promotes deeper sleep and supports overnight repair processes
Supports lean muscle maintenance while helping regulate fat metabolism
Helps maintain balanced and consistent growth hormone release patterns
CJC-1295 functions as a growth hormone releasing hormone analog that interacts with receptors responsible for stimulating growth hormone signaling pathways. Ipamorelin acts as a selective ghrelin receptor agonist that promotes growth hormone pulse activity through a separate but complementary mechanism.
When combined, these peptides influence two different regulatory pathways associated with endogenous growth hormone release. This dual-pathway activity allows researchers to examine coordinated signaling related to recovery processes, metabolic function, and regenerative biological pathways.
Compound: CJC-1295 / Ipamorelin Peptide Blend
Form: Lyophilized Powder
Chemical Name: CJC-1295 (Modified Growth Hormone Releasing Hormone Analog)
Ipamorelin (Pentapeptide Growth Hormone Secretagogue)
Molecular Weight: CJC-1295: ~3647.2 g/mol Ipamorelin: ~711.9 g/mol
Appearance: White to off-white sterile lyophilized powder
Research Application: Growth hormone secretagogue research, metabolic pathway studies, recovery signaling analysis, and peptide interaction research.
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose treat cure or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. This compound should only be handled by qualified professionals in appropriate research or laboratory settings.